2025-2026 Session
Change SessionH.218 (Act 16)
An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund
- Sponsor(s)
- Last Recorded Action
- Senate 5/14/2025 - House message: Governor approved bill on May 13, 2025
Bill/Resolution Text
NOTE: to print information that appears on a tab within the bill page, use the Print link on that tab.
An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund
Detailed Status
Regular Session 2025-2026
| Body | Date | Journal | Calendar | Location | Full Status |
|---|
An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund
Roll Call History
Regular Session 2025-2026
| Body | Date | Journal | Location | Full Status |
|---|
Although procedurally bills and resolutions are assigned to only one committee at a time, other committees may review the bill or resolution. This page contains results from both the assigned committee as well as other committees.
An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund
Committee Meetings
Regular Session 2025-2026
| Meeting Date | Committee |
|---|
An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund
Meeting Full List
Regular Session 2025-2026
Tuesday, February 18, 2025
- Committee(s):
- House Committee on Human Services
- 1:00 PM
-
H.218 - An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund
Walk-through
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Nolan Langweil, Principal Fiscal Analyst, Joint Fiscal Office
Wednesday, February 26, 2025
- Committee(s):
- House Committee on Human Services
- 10:25 AM
-
H.218 - An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund
Opioid Fund and H.218; review of previous legislation
Nolan Langweil, Principal Fiscal Analyst, Joint Fiscal Office
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
- 11:15 AM
-
H.218 - An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund
Mark Levine, Commissioner, Department of Health
Thursday, February 27, 2025
- Committee(s):
- House Committee on Human Services
- 2:00 PM
-
H.218 - An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund
Mark-up
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Nolan Langweil, Principal Fiscal Analyst, Joint Fiscal Office
- After Floor
-
H.218 - An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund
Committee discussion
Friday, February 28, 2025
- Committee(s):
- House Committee on Human Services
- 11:25 AM
-
H.218 - An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund
Committee discussion and possible vote
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
- 1:00 PM
-
H.218 - An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund
Discussion and vote
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Friday, March 14, 2025
- Committee(s):
- House Committee on Appropriations
- 9:30 AM
-
H.218 - An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund
Walk through
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Nolan Langweil, Principal Fiscal Analyst, Joint Fiscal Office
Rep. Eric Maguire, Reporter of the Bill, House Committee on Human Services
Richard Donahey, Chief Financial Officer, Agency of Human Services
Friday, March 21, 2025
- Committee(s):
- House Committee on Appropriations
- 9:00 AM
-
H.218 - An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund
Amendment and vote
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Nolan Langweil, Principal Fiscal Analyst, Joint Fiscal Office
Wednesday, March 26, 2025
- Committee(s):
- House Committee on Human Services
- 10:30 AM
-
H.218 - An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund
Review of House Appropriations amendment
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Nolan Langweil, Principal Fiscal Analyst, Joint Fiscal Office
Friday, March 28, 2025
- Committee(s):
- House Committee on Human Services
- 8:45 AM
-
H.218 - An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund
Review White Amendment
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Rep. Candice White, Sponsor
Tuesday, April 15, 2025
- Committee(s):
- Senate Committee on Health and Welfare
- 11:00 AM
-
H.218 - An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund
Introduction and walk-through
Rep. Theresa Wood, Sponsor
Nolan Langweil, Principal Fiscal Analyst, Joint Fiscal Office
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
David Mickenberg, Lobbyist, City of Burlington
Wednesday, April 16, 2025
- Committee(s):
- Senate Committee on Health and Welfare
- 9:00 AM
-
H.218 - An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund
Vote
Tuesday, April 22, 2025
- Committee(s):
- Senate Committee on Appropriations
- 1:00 PM
-
H.218 - An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund
Walk-Through and Vote
Nolan Langweil, Principal Fiscal Analyst, Joint Fiscal Office
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Committee Documents
An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund
Witnesses Who Testified
Regular Session 2025-2026
House Committee on Appropriations
- Richard Donahey, Chief Financial Officer, Agency of Human Services
- Nolan Langweil, Principal Fiscal Analyst, Joint Fiscal Office
- Rep. Eric Maguire, Reporter of the Bill, House Committee on Human Services
- Katie McLinn, Legislative Counsel, Office of Legislative Counsel
House Committee on Human Services
- Nolan Langweil, Principal Fiscal Analyst, Joint Fiscal Office
- Mark Levine, Commissioner, Department of Health
- Katie McLinn, Legislative Counsel, Office of Legislative Counsel
- Rep. Candice White, Sponsor
Senate Committee on Appropriations
- Nolan Langweil, Principal Fiscal Analyst, Joint Fiscal Office
- Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Senate Committee on Health and Welfare
- Nolan Langweil, Principal Fiscal Analyst, Joint Fiscal Office
- Katie McLinn, Legislative Counsel, Office of Legislative Counsel
- David Mickenberg, Lobbyist, City of Burlington
- Rep. Theresa Wood, Sponsor
Fiscal notes and materials available on this web page are provided for informational purposes only, and may not comprise all materials received by the Vermont Legislature or the final fiscal information related to a specific bill. The Legislature is not responsible for the accuracy of any information in these materials, and their posting does not constitute approval or endorsement by the Legislature.
Fiscal Information
Fiscal Notes and Related Documents
- H.218 (Act 16) – An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund, As Enacted
- H.218 – An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund, As Passed by the General Assembly
- H.218 – An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund, As Passed by the House of Representatives
- H.218 – An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund, As recommended by the House Committee on Appropriation, Draft 2.1
- H.218 – An act relating to fiscal 2026 appropriations from the Opioid Abatement Special Fund, As recommended by the House Committee on Human Services, Draft 5.1
No committee of conference members found for H.218 in the Regular Session 2025-2026.
An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund
Committee of Conference Meetings
Regular Session 2025-2026
| Meeting Date | Committee |
|---|
An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund
Committee of Conference Meeting Full List
Regular Session 2025-2026
No committee of conference meeting history found for H.218 in the Regular Session 2025-2026.
No committee of conference report found for H.218 in the Regular Session 2025-2026.
Act
An act relating to fiscal year 2026 appropriations from the Opioid Abatement Special Fund
Statutes Affected
Regular Session 2025-2026
| Statute |
|---|
| 18 V.S.A. § 4754. Limitation on prior authorization requirements |
| 18 V.S.A. § 4772. Opioid Settlement Advisory Committee |
| 18 V.S.A. § 4774. Opioid Abatement Special Fund |
